Date | Name | Shares | Transaction | Value |
Apr 26, 2024
| Michael X. Garrett Director |
3,743
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 26, 2024
| Maria T. Zuber Director |
15,647
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 26, 2024
| Kathleen M. Bader Director |
15,626
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 26, 2024
| James L. Ziemer Director |
15,791
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 26, 2024
| R. Kerry Clark Director |
6,273
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 26, 2024
| Lionel L. Nowell Director |
15,634
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 26, 2024
| Thomas A. Kennedy Director |
5,007
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 26, 2024
| Richard F. Ambrose Director |
6,447
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 26, 2024
| Deborah Lee James Director |
15,646
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2024
| Frank T. Connor Executive Vice President & CFO |
153,961
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $88.68 per share |
13,653,261.48
|
Mar 6, 2024
| Julie G. Duffy EVP and CHRO |
34,083
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $88.68 per share |
3,022,480.44
|
Mar 6, 2024
| E. Robert Lupone EVP, General Counsel & Secy |
17,297
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2024
| Julie G. Duffy EVP and CHRO |
13,655
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2024
| E. Robert Lupone EVP, General Counsel & Secy |
98,794
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $88.68 per share |
8,761,051.92
|
Mar 6, 2024
| E. Robert Lupone EVP, General Counsel & Secy |
103,279
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2024
| Frank T. Connor Executive Vice President & CFO |
40,575
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2024
| Scott C. Donnelly Chairman, President & CEO; Director |
717,701
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2024
| Frank T. Connor Executive Vice President & CFO |
164,148
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2024
| Scott C. Donnelly Chairman, President & CEO; Director |
142,531
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2024
| Scott C. Donnelly Chairman, President & CEO; Director |
711,951
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $88.68 per share |
63,135,814.68
|